Kaoru Murakami

Systematic chemical screening identifies disulfiram as a repurposed drug that enhances sensitivity to cisplatin in bladder cancer: a summary of preclinical studies

Yuki Kita, Akihiro Hamada, Ryoichi Saito et al. · British Journal of Cancer · 2019 · 59 citations · Full text

Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder

Norihiko Masuda, Kaoru Murakami, Yuki Kita et al. · American Journal Of Pathology · 2020 · 32 citations · Full text

Tumor Biology, Lineage Plasticity, Genitourinary Cancer +10

PAI-1 is a potential transcriptional silencer that supports bladder cancer cell activity

Hideki Furuya, Yuka Sasaki, Runpu Chen et al. · Scientific Reports · 2022 · 27 citations · Full text

Sequential Use of Androgen Receptor Axis-targeted Agents in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Retrospective Analysis With 3-Year Follow-up

Takashi Kobayashi, Naoki Terada, Takahiro Kimura et al. · Clinical Genitourinary Cancer · 2019 · 13 citations

Urology, Oncology, Sequential Use +8

Antitumor effect of WEE1 blockade as monotherapy or in combination with cisplatin in urothelial cancer

Kaoru Murakami, Yuki Kita, Toru Sakatani et al. · Cancer Science · 2021 · 13 citations · Full text